Displaying 61 - 72 of 463
Immune-Mediated and Cholestatic Diseases

GSK: "Practical tips towards providing holistic care to patients with PBC" (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" (Complete Session)

Webcasts
View
Viral Hepatitis

Gilead: "Headlines In Hepatitis Delta: The Latest Advances In Care in Hepatitis Delta" (Complete Session)

Webcasts
View
Viral Hepatitis

Gilead: “From Headlines To The Clinic: Expert Approaches To Patient Care in Hepatitis Delta” (Complete Session)

Webcasts
View
General Hepatology

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: "Looking To The Future Of Hepatitis B: An Expert Review Of Quantitative Hepatitis B Surface Antigen Assessment” (Complete...

Webcasts
View
Metabolism, Alcohol & Toxicity

Takeda: "Alpha-1 antitrypsin deficiency (AATD) - Associated liver disease: More common than you may think" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Ipsen: "Scratching beyond the surface in PBC: From current unmet medical needs to future prospects" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum Pharmaceuticals, Inc: "Meet the Experts in Cholestatic Liver Disease" (Complete Session)

Webcasts
View
Displaying 61 - 72 of 463